This report, written by Robert Seifert and Rachel Gershon of the Center for Health Law and Economics at UMass Medical School, examines the key components of the most recent Massachusetts health reform law - Chapter 224 of the Acts of 2012 - as they pertain to the Massachusetts Medicaid program (“MassHealth”). Under the new law, MassHealth will be subject to the annual spending growth benchmark and will be required to implement alternative payment arrangements for most of its members, among other new requirements and responsibilities.
This poll, fielded in late September 2011 and led by Robert Blendon at the Harvard Opinion Research Program, probed 1002 Massachusetts adults on various questions surrounding health care costs, including their perceptions of major cost drivers, who they believe should take the lead on addressing costs and how important is it for the state to take major action. The results reveal that the public is greatly concerned over rising costs and ready for the state to take major actions to tackle them.
On November 13, 2009, MMPI partnered with the Massachusetts Health Policy Forum and Community Catalyst to sponsor a forum exploring efforts in Massachusetts to improve quality and control Medicaid prescription drug costs. At the forum, an issue brief was released that detailed implementation of a preferred drug list in the MassHealth program. In addition, speakers talked about the array of tools available to states to improve prescribing and reduce cost growth.
This report from MMPI and the Massachusetts Budget and Policy Center looks at Medicaid spending in relation not only to total public spending, but also to state revenues and overall economic growth. It concludes that, between Fiscal Years 1994 and 2005, Medicaid spending changed very little in relation to the economy as a whole, and therefore was sustainable given the economic growth over that same period. Looking at Medicaid spending with this broader view provides a new context for policy makers as they think about the Medicaid budget, now and in the future.